Granite Point Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Granite Point Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,600	Closed	-$1.14M	–	142
2018 Q3	$1.14M	Sell	6,600 -400	-6%	-$57.7K	0.08%	78
2018 Q2	$977K	Sell	7,000 -22,200	-76%	-$3.15M	0.09%	76
2018 Q1	$3.29M	Sell	29,200 -10,800	-27%	-$1.36M	0.32%	23
2017 Q4	$5.28M	Buy	+40,000	New	+$4.7M	0.52%	11

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Granite Point Capital Management's GWPH Position: Q4 2018 in Review

Granite Point Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018, closing a stake of 6,600 shares — an estimated $1.14M sold.

Granite Point Capital Management first reported a position in GWPH in Q4 2017 and held it in 4 quarters. The position peaked at $5.28M in Q4 2017. 277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

Granite Point Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
Granite Point Capital Management sold 6,600 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2018, an estimated $1.14M.
Granite Point Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 4 quarters.
Granite Point Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5.28M in Q4 2017.
277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on Granite Point Capital Management's 13F filing for Q4 2018, filed 5 Feb 2019.